Groowe
/
Newsroom
/ JUNS
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JUNS
News
Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
globenewswire.com
Nov 5, 2025 2:36 PM
JUNS
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
globenewswire.com
Oct 27, 2025 1:31 PM
JUNS
← Newer
Page 7 of 7
Older →
